Welch & Forbes’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,237
Closed -$278K 378
2022
Q2
$278K Buy
+8,237
New +$289K 0.01% 339
2021
Q4
Sell
-12,852
Closed -$422K 395
2021
Q3
$422K Sell
12,852
-18,612
-59% -$596K 0.01% 298
2021
Q2
$952K Buy
+31,464
New +$1.04M 0.02% 230

Other funds holding OGN

Welch & Forbes's OGN Position: Q3 2022 in Review

Welch & Forbes sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 8,237 shares — an estimated $278K sold.

Welch & Forbes first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $952K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Welch & Forbes reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Welch & Forbes sold 8,237 Organon & Co shares in Q3 2022, an estimated $278K.
  • Welch & Forbes first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
  • Welch & Forbes's Organon & Co position peaked at $952K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Welch & Forbes's 13F filing for Q3 2022, filed 31 Oct 2022.